Emcure Pharmaceuticals Revenue Growth in India: A Detailed Analysis
Revenue Contribution and Percentage Increase
Emcure Pharmaceuticals Limited (Emcure) experienced substantial revenue growth in India during the fiscal year 2023-24 (FY24). Revenue from India accounted for 5,084 crores and 5,316 crores in FY23 and FY24, respectively, representing 50.84% and 53.16% of the company's total revenue in those fiscal years.
Growth Percentage and Absolute Increase
Emcure recorded an impressive revenue growth of 11.33% in FY24, amounting to Rs. 6,715 crores. This represents an absolute increase of over Rs. 671 crores compared to the previous fiscal year.
Summary of Financial Information
The following table summarizes key financial information of Emcure Pharmaceuticals Limited for the financial year ending on 31 March:
| Financial Information | FY23 | FY24 |
|---|---|---|
| Revenue | Rs. 5,084 crores | Rs. 5,316 crores |
| Revenue Growth | 11.33% | - |
| Total Revenue | - | Rs. 6,715 crores |
0 Comments